Your browser is no longer supported. Please, upgrade your browser.
DXCM [NASD]
DexCom, Inc.
IndexS&P 500 P/E104.45 EPS (ttm)5.34 Insider Own0.60% Shs Outstand96.70M Perf Week3.21%
Market Cap54.15B Forward P/E157.92 EPS next Y3.53 Insider Trans-19.50% Shs Float96.25M Perf Month10.33%
Income530.60M PEG6.37 EPS next Q0.63 Inst Own99.90% Short Float4.00% Perf Quarter31.85%
Sales2.17B P/S24.96 EPS this Y362.20% Inst Trans3.06% Short Ratio5.82 Perf Half Y55.01%
Book/sh20.66 P/B27.00 EPS next Y42.94% ROA12.50% Target Price522.55 Perf Year43.27%
Cash/sh26.62 P/C20.95 EPS next 5Y16.40% ROE29.40% 52W Range305.63 - 567.81 Perf YTD50.86%
Dividend- P/FCF538.84 EPS past 5Y55.20% ROI15.80% 52W High-1.86% Beta0.75
Dividend %- Quick Ratio5.30 Sales past 5Y36.80% Gross Margin70.00% 52W Low82.33% ATR13.88
Employees5500 Current Ratio5.80 Sales Q/Q31.70% Oper. Margin15.90% RSI (14)65.86 Volatility2.47% 2.57%
OptionableYes Debt/Eq0.00 EPS Q/Q32.30% Profit Margin24.50% Rel Volume0.57 Prev Close557.76
ShortableYes LT Debt/Eq0.89 EarningsJul 29 AMC Payout0.00% Avg Volume660.52K Price557.27
Recom1.60 SMA203.33% SMA5010.51% SMA20035.92% Volume221,575 Change-0.09%
Jul-21-21Resumed Cowen Outperform $540 → $525
May-28-21Upgrade Wells Fargo Underweight → Equal Weight $380
May-25-21Initiated Barclays Overweight $500
Apr-15-21Initiated Atlantic Equities Overweight $438
Jan-06-21Upgrade UBS Neutral → Buy $410 → $445
Oct-02-20Downgrade Wells Fargo Equal Weight → Underweight $420 → $350
May-27-20Reiterated Piper Sandler Overweight $375 → $450
May-14-20Initiated Wells Fargo Equal Weight $420
Mar-05-20Initiated Citigroup Buy $330
Nov-07-19Upgrade Guggenheim Neutral → Buy
Nov-07-19Reiterated Canaccord Genuity Buy $185 → $195
Oct-23-19Initiated Stifel Buy
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Sep-15-21 10:30AM  
Sep-14-21 11:05AM  
Sep-13-21 01:00PM  
12:58PM  
08:30AM  
Sep-05-21 05:39AM  
Sep-02-21 08:45AM  
Aug-28-21 08:00AM  
Aug-27-21 08:30AM  
Aug-24-21 07:25AM  
Aug-10-21 08:30AM  
05:43AM  
Aug-03-21 09:49AM  
Jul-31-21 10:41PM  
Jul-30-21 05:45PM  
01:23PM  
11:39AM  
09:13AM  
05:08AM  
Jul-29-21 11:32PM  
05:35PM  
04:02PM  
Jul-23-21 07:54AM  
Jul-22-21 03:03PM  
Jul-19-21 10:32AM  
02:32AM  
Jul-15-21 04:51PM  
Jul-07-21 08:45AM  
Jul-06-21 08:46AM  
Jul-01-21 04:58PM  
Jun-25-21 08:45AM  
07:41AM  
Jun-24-21 10:09AM  
10:00AM  
Jun-22-21 09:14AM  
Jun-18-21 06:00AM  
Jun-16-21 04:00PM  
Jun-15-21 11:27AM  
Jun-14-21 06:00AM  
Jun-13-21 04:11AM  
Jun-11-21 01:28PM  
Jun-10-21 10:22AM  
Jun-03-21 11:11AM  
Jun-01-21 08:00AM  
06:00AM  
May-27-21 08:45AM  
06:18AM  
May-26-21 06:00AM  
May-24-21 03:17PM  
May-20-21 06:24AM  
May-14-21 01:19PM  
02:56AM  
May-13-21 04:21PM  
10:21AM  
May-10-21 05:21PM  
May-04-21 06:34PM  
Apr-30-21 12:06PM  
10:24AM  
09:21AM  
Apr-29-21 08:31PM  
05:43PM  
05:15PM  
04:47PM  
04:02PM  
02:30PM  
Apr-28-21 09:13AM  
Apr-27-21 09:02AM  
08:38AM  
06:43AM  
Apr-26-21 08:53AM  
Apr-23-21 08:45AM  
Apr-22-21 12:33PM  
Apr-21-21 07:12AM  
Apr-20-21 09:00AM  
Apr-18-21 05:12AM  
Apr-16-21 04:56PM  
Apr-07-21 03:00AM  
Apr-01-21 04:15PM  
06:33AM  
Mar-25-21 01:05PM  
Mar-24-21 01:18PM  
Mar-23-21 01:18PM  
10:12AM  
08:30AM  
Mar-22-21 07:14PM  
Mar-19-21 02:53AM  
Mar-18-21 12:02PM  
Mar-10-21 08:00AM  
Mar-09-21 07:40AM  
Mar-08-21 08:54AM  
Mar-03-21 11:23AM  
Feb-19-21 11:51AM  
Feb-18-21 06:06AM  
Feb-17-21 08:45AM  
01:48AM  
Feb-12-21 10:40AM  
10:38AM  
Feb-11-21 10:31PM  
05:25PM  
04:46PM  
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAYER KEVIN RChairman, CEO & PresidentSep 15Sale540.586,0003,243,46296,705Sep 16 07:01 PM
Patterson ChadEVP, Global MarketingSep 13Sale541.4715684,4699,744Sep 15 04:14 PM
Blackford Quentin S.Chief Operating OfficerSep 10Sale558.331,519848,10319,280Sep 10 04:15 PM
Flynn Paul REVP, Global RevenueSep 10Sale558.33626349,51510,928Sep 13 08:00 PM
Selvaraj Shelly RamasamySVP Information TechnologySep 10Sale558.33681380,22313,014Sep 13 08:19 PM
Selvaraj Shelly RamasamySVP Information TechnologySep 09Sale546.142,2231,214,05913,695Sep 13 08:19 PM
Balo Andrew K*Sep 09Sale546.785,5973,060,3377,553Sep 13 08:19 PM
SAYER KEVIN RChairman, CEO & PresidentSep 09Sale541.363,0171,633,280102,705Sep 13 08:01 PM
Shrishrimal SumiSVP Chief Risk OfficerSep 09Sale541.37407220,33912,234Sep 13 08:01 PM
Sylvain Jereme MEVP, Chief Financial OfficerSep 09Sale541.36407220,33613,526Sep 13 08:01 PM
Flynn Paul REVP, Global RevenueSep 09Sale541.36752407,10611,554Sep 13 08:00 PM
Leach Jacob StevenEVP Chief Technology OfficerSep 09Sale541.371,263683,74869,322Sep 13 08:00 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerSep 09Sale541.36987534,32716,254Sep 13 08:00 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesSep 09Sale541.371,263683,74747,822Sep 13 08:00 PM
Patterson ChadEVP, Global MarketingSep 09Sale541.37291157,5389,900Sep 13 08:00 PM
Abbey DonaldEVP Quality and Regulatory AffSep 09Sale541.371,263683,74748,674Sep 13 07:59 PM
Blackford Quentin S.Chief Operating OfficerSep 09Sale547.329,4625,178,69920,799Sep 10 04:15 PM
Blackford Quentin S.Chief Operating OfficerSep 08Sale545.877,6814,192,84630,261Sep 10 04:15 PM
Sylvain Jereme MEVP, Chief Financial OfficerSep 07Sale545.41587320,15613,933Sep 08 06:54 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerAug 26Sale517.24500258,62017,241Aug 27 06:38 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesAug 23Sale516.401,078556,67849,085Aug 25 04:59 PM
Balo Andrew K*Aug 03Sale515.872,7571,422,24710,652Aug 04 08:36 PM
Leach Jacob StevenEVP Chief Technology OfficerJul 30Sale476.7012,0875,761,87370,554Aug 02 06:19 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerJul 26Sale458.79500229,39517,741Jul 27 06:04 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesJul 23Sale452.181,079487,89750,163Jul 27 06:03 PM
Shrishrimal SumiSVP Chief Risk OfficerJul 16Sale450.00400180,00012,586Jul 16 08:40 PM
Balo Andrew K*Jul 06Sale430.142,9741,279,22813,409Jul 08 07:45 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerJun 28Sale431.49500215,74518,241Jun 29 07:05 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesJun 23Sale426.921,079460,65151,242Jun 24 05:59 PM
SKYLER JAY SDirectorJun 22Sale426.3720,0008,527,40613,968Jun 24 05:59 PM
Shrishrimal SumiSVP Chief Risk OfficerJun 11Sale401.09400160,43612,986Jun 15 06:14 PM
Leach Jacob StevenEVP Chief Technology OfficerJun 09Sale395.0022,7558,988,22582,641Jun 10 05:43 PM
AUGUSTINOS NICHOLASDirectorJun 03Sale366.99806295,7943,110Jun 07 07:35 PM
Balo Andrew K*Jun 03Sale375.002,391896,62516,383Jun 07 07:33 PM
Blackford Quentin S.Chief Operating OfficerMay 28Sale375.007,2232,708,62537,942Jun 01 09:14 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerMay 26Sale350.00500175,00018,741May 27 05:27 PM
Shrishrimal SumiSVP Chief Risk OfficerMay 25Sale354.791,461518,34813,386May 27 05:28 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesMay 24Sale348.711,079376,26052,321May 26 04:57 PM
Sylvain Jereme MEVP, Chief Financial OfficerMay 24Sale346.74600208,04414,508May 26 04:58 PM
SAYER KEVIN RChairman, CEO & PresidentMay 03Sale379.885,5352,102,626105,722May 05 05:35 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerApr 26Sale415.83500207,91519,241Apr 27 06:27 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesApr 23Sale410.311,079442,72753,400Apr 26 08:09 PM
Flynn Paul REVP, Global RevenueApr 15Sale400.00758303,20012,306Apr 16 04:44 PM
SAYER KEVIN RChairman, CEO & PresidentApr 05Sale366.676,2212,281,082111,257Apr 07 05:05 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerMar 26Sale350.00500175,00019,741Mar 30 05:45 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 23Sale360.491,109399,7886,654Mar 24 08:18 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesMar 23Sale360.491,079388,96754,479Mar 24 08:18 PM
Selvaraj Shelly RamasamySVP Information TechnologyMar 11Sale355.861,867664,39116,136Mar 12 05:41 PM
Selvaraj Shelly RamasamySVP Information TechnologyMar 10Sale362.922,700979,87618,003Mar 12 05:41 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 10Sale362.925,5662,019,99655,558Mar 12 05:40 PM
SAYER KEVIN RChairman, CEO & PresidentMar 10Sale362.9214,0445,096,806117,478Mar 12 05:40 PM
Leach Jacob StevenEVP Chief Technology OfficerMar 10Sale362.925,3531,942,695105,396Mar 12 05:38 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerMar 10Sale362.923,4711,259,68520,241Mar 12 05:39 PM
Blackford Quentin S.Chief Operating Officer & CFOMar 10Sale362.226,5092,357,68845,165Mar 12 05:38 PM
Abbey DonaldEVP Quality and Regulatory AffMar 10Sale362.925,5662,019,99649,937Mar 12 05:36 PM
Balo Andrew K*Mar 10Sale362.925,5662,019,99635,307Mar 12 05:37 PM
Sylvain Jereme MSVP, Finance & CAOMar 10Sale362.92941341,50515,108Mar 12 05:42 PM
SAYER KEVIN RChairman, CEO & PresidentMar 09Sale361.113,8571,392,796131,522Mar 10 07:29 PM
Selvaraj Shelly RamasamySVP Information TechnologyMar 09Sale356.9415254,25520,703Mar 10 07:29 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerFeb 26Sale396.79500198,39518,078Mar 02 07:31 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerFeb 24Sale404.001,110448,4407,763Feb 26 06:01 PM
Sylvain Jereme MSVP, Finance & CAOFeb 24Sale404.00600242,40010,700Feb 26 06:02 PM
Pacelli Steven RobertEVP Strategy and Corporate DevFeb 23Sale406.981,079439,13155,823Feb 24 07:57 PM
Pacelli Steven RobertEVP Strategy and Corporate DevFeb 19Sale420.011,800756,02556,902Feb 23 06:33 PM
AUGUSTINOS NICHOLASDirectorFeb 16Sale412.031,875772,55610,092Feb 17 09:36 PM
SAYER KEVIN RChairman, CEO & PresidentFeb 01Sale378.1712,4684,714,965131,934Feb 03 07:34 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerJan 27Sale359.70500179,85018,578Jan 29 05:08 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJan 22Sale368.841,110409,4078,873Jan 25 08:21 PM
Pacelli Steven RobertEVP Strategy and Corporate DevJan 22Sale368.821,079397,96058,702Jan 25 08:21 PM
SAYER KEVIN RChairman, CEO & PresidentJan 13Sale353.557,0732,500,653144,402Jan 14 05:06 PM
SAYER KEVIN RChairman, CEO & PresidentJan 12Sale362.0939,94914,465,252151,475Jan 14 05:06 PM
AUGUSTINOS NICHOLASDirectorJan 06Sale375.00625234,37511,967Jan 07 04:40 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJan 04Sale366.0611,0254,035,81221,524Jan 06 05:10 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerDec 28Sale355.39500177,69519,078Dec 29 08:58 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerDec 23Sale359.921,110399,5169,983Dec 28 05:43 PM
Pacelli Steven RobertEVP Strategy and Corporate DevDec 23Sale359.851,079388,27659,781Dec 28 05:43 PM
AUGUSTINOS NICHOLASDirectorDec 16Sale354.551,250443,18212,592Dec 18 07:53 PM
Heller Bridgette PDirectorDec 15Sale356.65375133,7443,448Dec 17 05:12 PM
SAYER KEVIN RChairman, CEO & PresidentDec 01Sale322.1813,2334,263,358115,514Dec 03 05:11 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerDec 01Sale325.006,1542,000,05019,578Dec 03 05:11 PM
Sylvain Jereme MSVP, Finance & CAONov 24Sale320.37600192,22211,300Nov 25 04:50 PM
Pacelli Steven RobertEVP Strategy and Corporate DevNov 23Sale318.991,079344,19060,860Nov 25 04:50 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerNov 23Sale318.991,110354,07911,093Nov 25 04:50 PM
FOLETTA MARK GDirectorNov 16Sale341.321,000341,32013,202Nov 18 06:57 PM
Sylvain Jereme MSVP, Finance & CAONov 10Sale336.22632212,49111,900Nov 12 05:39 PM
SAYER KEVIN RPresident, CEO and ChairmanOct 29Sale340.1413,8304,704,197128,747Oct 30 05:01 PM
Pacelli Steven RobertEVP Strategy and Corporate DevOct 23Sale403.181,079435,03061,939Oct 27 06:20 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerOct 23Sale403.101,110447,44412,203Oct 27 06:19 PM
FOLETTA MARK GDirectorOct 15Sale396.821,000396,81914,202Oct 19 04:30 PM
Pacelli Steven RobertEVP Strategy and Corporate DevOct 01Sale420.0020084,00063,018Oct 02 06:08 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 30Sale410.322,000820,63763,218Oct 02 06:08 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 25Sale400.072,000800,13765,218Sep 28 05:35 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerSep 24Sale380.951,530582,8610Sep 28 05:35 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 23Sale395.111,079426,32467,218Sep 24 04:30 PM